FEMY — Femasys Income Statement
0.000.00%
- $25.33m
- $14.37m
- $1.07m
- 31
- 13
- 62
- 27
Annual income statement for Femasys, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 0.929 | 1.04 | 1.18 | 1.21 | 1.07 |
Cost of Revenue | |||||
Gross Profit | 0.705 | 0.731 | 0.809 | 0.764 | 0.692 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Depreciation and Amortization | |||||
Total Operating Expenses | 12.6 | 7.97 | 9.52 | 12.8 | 15.6 |
Operating Profit | -11.6 | -6.93 | -8.34 | -11.6 | -14.5 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -11.3 | -6.91 | -7.53 | -11.4 | -14.2 |
Provision for Income Taxes | |||||
Net Income After Taxes | -11.3 | -6.91 | -7.54 | -11.4 | -14.2 |
Net Income Before Extraordinary Items | |||||
Net Income | -11.3 | -6.91 | -7.54 | -11.4 | -14.2 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -11.3 | -6.91 | -7.54 | -11.4 | -14.2 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.958 | -0.588 | -1.12 | -0.964 | -0.926 |
Dividends per Share |